Elettra-Sincrotrone Trieste S.C.p.A. website uses session cookies which are required for users to navigate appropriately and safely. Session cookies created by the Elettra-Sincrotrone Trieste S.C.p.A. website navigation do not affect users' privacy during their browsing experience on our website, as they do not entail processing their personal identification data. Session cookies are not permanently stored and indeed are cancelled when the connection to the Elettra-Sincrotrone Trieste S.C.p.A. website is terminated.
More info
OK

AntiHelix, a new training tool for young researchers

The AntiHelix project website is online


Helicases are molecular machines able to unwind double helices and other nucleic acids structures, and are thus implicated in all the cell mechanisms that involve DNA and RNA. Due to their importance in the cell, they are emerging as a new class of antibacterial, antiviral and ant-cancer drug targets.
The AntiHelix consortium (funded by the H2020-MSCA-ITN programme) includes academic and industrial partners with the aim of training young researchers, able to use a wide range of interdisciplinary approaches (cell bilogy, biochemistry, molecular biology, structural biology, single molecule techniques, structure-based drug design, clinical oncology) for the characterisation of the structure and function of medically relevant human helicases, to design novel inhibitors as putative drugs against cancer.

 

 

 
Last Updated on Tuesday, 05 November 2019 17:00